US4269846A
(en)
|
1979-10-29 |
1981-05-26 |
Usv Pharmaceutical Corporation |
Heterocyclic compounds useful as anti-allergy agents
|
US5137876A
(en)
|
1990-10-12 |
1992-08-11 |
Merck & Co., Inc. |
Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
JP4516690B2
(en)
|
1998-08-11 |
2010-08-04 |
ノバルティス アーゲー |
Isoquinoline derivatives having angiogenesis inhibitory activity
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0011092D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (III)
|
PT1294358E
(en)
|
2000-06-28 |
2004-12-31 |
Smithkline Beecham Plc |
MOORING PROCESS BY HUMIDITY
|
EP1436291B1
(en)
|
2001-09-19 |
2009-01-14 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
FR2831536A1
(en)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
NOVEL BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS KDR INHIBITORS
|
JP5039268B2
(en)
|
2001-10-26 |
2012-10-03 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
Benzimidazoles and analogs and their use as protein kinase inhibitors
|
CN1582150B
(en)
|
2001-10-30 |
2011-09-07 |
诺瓦提斯公司 |
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
|
DE10207843A1
(en)
|
2002-02-15 |
2003-09-04 |
Schering Ag |
Microlia inhibitors for interruption of interleukin 12 and IFN-gamma mediated immune responses
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
CL2003002353A1
(en)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
COMPOUNDS DERIVED FROM DIAMINOTRIAZOLS, INHIBITORS D ELA PROTEINA QUINASA; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND ITS USE OF THE COMPOUND IN THE TREATMENT OF DISEASES OF ALLERGIC DISORDERS, PROLIFERATION, AUTOIMMUNES, CONDIC
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
US7157460B2
(en)
|
2003-02-20 |
2007-01-02 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
US7186832B2
(en)
*
|
2003-02-20 |
2007-03-06 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
EP1599474B1
(en)
|
2003-03-04 |
2013-04-24 |
California Institute Of Technology |
Heterocyclic oligomeric compounds for DNA recognition
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
EP1651631A1
(en)
|
2003-08-01 |
2006-05-03 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
AR045944A1
(en)
|
2003-09-24 |
2005-11-16 |
Novartis Ag |
ISOQUINOLINE DERIVATIVES 1.4-DISPOSED
|
AU2004282219C1
(en)
*
|
2003-10-15 |
2009-12-17 |
Osi Pharmaceuticals, Inc. |
Imidazo [1, 5 - a] pyrazine tyrosine kinase inhibitors
|
WO2005118580A2
(en)
|
2004-05-12 |
2005-12-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health |
Tricyclic compounds as inhibitors of the hypoxic signaling pathway
|
EP1758892B1
(en)
|
2004-06-10 |
2012-10-17 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
AU2005309019A1
(en)
|
2004-11-24 |
2006-06-01 |
Novartis Ag |
Combinations of JAK inhibitors and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitors
|
CA2617532A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
|
CA2620223A1
(en)
|
2005-09-02 |
2007-03-08 |
Abbott Laboratories |
Novel imidazo based heterocycles
|
JP2009541268A
(en)
|
2006-06-22 |
2009-11-26 |
ビオヴィトルム・アクチボラゲット(プブリクト) |
Pyridine and pyrazine derivatives as MNK kinase inhibitors
|
CA2681813A1
(en)
|
2007-03-27 |
2009-01-08 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
DE102007035333A1
(en)
|
2007-07-27 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel substituted arylsulfonylglycines, their preparation and their use as pharmaceuticals
|
GB0716292D0
(en)
|
2007-08-21 |
2007-09-26 |
Biofocus Dpi Ltd |
Imidazopyrazine compounds
|
NZ585139A
(en)
|
2007-11-16 |
2012-05-25 |
Incyte Corp |
4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as jak inhibitors
|
EP2234486A4
(en)
|
2007-12-19 |
2011-09-14 |
Scripps Research Inst |
Benzimidazoles and analogs as rho kinase inhibitors
|
WO2009123776A2
(en)
|
2008-01-15 |
2009-10-08 |
Siga Technologies, Inc. |
Antiviral drugs for treatment of arenavirus infection
|
ATE555116T1
(en)
|
2008-02-26 |
2012-05-15 |
Merck Sharp & Dohme |
AHCY HYDROLASE INHIBITORS FOR THE TREATMENT OF HYPERHOMOCYSTEINEMIA
|
ES2602577T3
(en)
|
2008-03-11 |
2017-02-21 |
Incyte Holdings Corporation |
Azetidine and cyclobutane derivatives as JAK inhibitors
|
WO2009133127A1
(en)
|
2008-04-30 |
2009-11-05 |
Merck Serono S.A. |
Fused bicyclic compounds and use thereof as pi3k inhibitors
|
WO2009158118A2
(en)
|
2008-05-30 |
2009-12-30 |
University Of Notre Dame Du Lac |
Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
|
WO2010051245A1
(en)
|
2008-11-03 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Benzimidazole and aza-benzimidazole carboxamides
|
TW201028399A
(en)
|
2008-11-27 |
2010-08-01 |
Shionogi & Co |
Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
|
GB0822981D0
(en)
|
2008-12-17 |
2009-01-21 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
WO2010135014A1
(en)
|
2009-02-27 |
2010-11-25 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
EA022629B1
(en)
*
|
2009-04-16 |
2016-02-29 |
Фундасьон Сентро Насиональ Де Инвестигасьонес Онколохикас Карлос Iii |
Imidazopyrazines for use as kinase inhibitors
|
AR076794A1
(en)
|
2009-05-22 |
2011-07-06 |
Incyte Corp |
DERIVATIVES OF N- (HETERO) ARIL-PIRROLIDINA DE PIRAZOL-4-IL-PIRROLO [2,3-D] PIRIMIDINES AND PIRROL-3-IL-PIRROLO [2,3-D] PYRIMIDINS AS INHIBITORS OF THE JANUS KINASE AND COMPOSITIONS PHARMACEUTICS THAT CONTAIN THEM
|
NZ597050A
(en)
|
2009-06-29 |
2014-02-28 |
Incyte Corp |
Pyrimidinones as pi3k inhibitors
|
AR078012A1
(en)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
HETEROCICLIC DERIVATIVES OF PIRAZOL-4-IL-PIRROLO (2,3-D) PYRIMIDINS AS INHIBITORS OF THE QUANASA JANUS
|
US8680108B2
(en)
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
WO2011099832A2
(en)
|
2010-02-12 |
2011-08-18 |
Crystalgenomics, Inc. |
Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
|
AR080754A1
(en)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS
|
MX347851B
(en)
|
2010-03-10 |
2017-05-16 |
Incyte Corp |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors.
|
JP2013523766A
(en)
|
2010-03-31 |
2013-06-17 |
グラクソ グループ リミテッド |
Imidazolyl-imidazole as a kinase inhibitor
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
US8877707B2
(en)
|
2010-05-24 |
2014-11-04 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
WO2011149874A2
(en)
|
2010-05-26 |
2011-12-01 |
Schering Corporation |
N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
PE20141044A1
(en)
|
2010-10-13 |
2014-09-07 |
Millennium Pharm Inc |
HETEROARYLS AND THEIR USES
|
SG190839A1
(en)
|
2010-11-19 |
2013-07-31 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
EP2640725B1
(en)
|
2010-11-19 |
2015-01-07 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
US8729102B2
(en)
|
2010-11-30 |
2014-05-20 |
Takeda Pharmaceutical Company Limited |
Bicyclic compound
|
AR084366A1
(en)
|
2010-12-20 |
2013-05-08 |
Incyte Corp |
N- (1- (REPLACED PHENYL) ETIL) -9H-PURIN-6-AMINAS AS PI3K INHIBITORS
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
US8673905B2
(en)
|
2011-03-17 |
2014-03-18 |
Hoffmann-La Roche Inc. |
Imidazo pyrazines
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
US9029389B2
(en)
|
2011-04-21 |
2015-05-12 |
Institut Pasteur Korea |
Anti-inflammation compounds
|
JP6463631B2
(en)
|
2011-06-09 |
2019-02-06 |
ライゼン・ファーマシューティカルズ・エスアー |
Novel compounds as modulators of GPR-119
|
AR086983A1
(en)
|
2011-06-20 |
2014-02-05 |
Incyte Corp |
DERIVATIVES OF AZETIDINIL FENIL, PIRIDIL OR PIRAZINIL CARBOXAMIDA AS JAK INHIBITORS
|
TW201313721A
(en)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
Cyclohexyl azetidine derivatives as JAK inhibitors
|
BR122019020716B1
(en)
|
2011-09-02 |
2021-02-17 |
Incyte Holdings Corporation |
heterocyclylamines as pi3k inhibitors and pharmaceutical composition comprising them
|
ES2588186T3
(en)
*
|
2012-01-10 |
2016-10-31 |
Bayer Intellectual Property Gmbh |
Imidazopyrazines substituted as Akt kinase inhibitors
|
JP5854390B2
(en)
|
2012-03-01 |
2016-02-09 |
学校法人兵庫医科大学 |
Novel benzimidazole derivatives and uses thereof
|
AR090548A1
(en)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS
|
AR091079A1
(en)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
DERIVATIVES OF PIRROLOPIRIMIDINA AND PIRROLOPIRIDINA REPLACED WITH PIPERIDINILCICLOBUTILO AS JAK INHIBITORS
|
EP2857396B1
(en)
|
2012-05-31 |
2018-11-21 |
Sumitomo Chemical Co., Ltd |
Fused heterocyclic compounds for pest control
|
ES2689429T3
(en)
|
2012-07-13 |
2018-11-14 |
Ucb Biopharma Sprl |
Imidazopyridine derivatives as modulators of TNF activity
|
NZ707495A
(en)
|
2012-11-01 |
2019-01-25 |
Incyte Holdings Corp |
Tricyclic fused thiophene derivatives as jak inhibitors
|
TWI657090B
(en)
|
2013-03-01 |
2019-04-21 |
英塞特控股公司 |
USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kδ RELATED DISORDERS
|
US8999992B2
(en)
|
2013-03-15 |
2015-04-07 |
Vm Pharma Llc |
Crystalline forms of tryosine kinase inhibitors and their salts
|
WO2014149207A2
(en)
|
2013-03-15 |
2014-09-25 |
Dow Agrosciences Llc |
Benzimidazole-based insecticidal compositions and related methods
|
WO2014153529A1
(en)
|
2013-03-22 |
2014-09-25 |
The Scripps Research Institute |
Substituted benzimidazoles as nociceptin receptor modulators
|
WO2014182954A1
(en)
|
2013-05-08 |
2014-11-13 |
Colorado Seminary, Which Owns And Operates The University Of Denver |
Antibiotic and anti-parasitic agents that modulate class ii fructose 1,6-bisphosphate aldolase
|
DK3786162T3
(en)
|
2013-05-17 |
2023-10-09 |
Incyte Holdings Corp |
BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS
|
MY184572A
(en)
|
2013-07-17 |
2021-04-05 |
Otsuka Pharma Co Ltd |
Cyanotriazole compounds
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10064866B2
(en)
|
2014-04-08 |
2018-09-04 |
Incyte Corporation |
Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors
|
EP2930048A1
(en)
|
2014-04-10 |
2015-10-14 |
Johnson Controls Automotive Electronics SAS |
Head up display projecting visual information onto a screen
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
EA201790502A1
(en)
|
2014-09-16 |
2017-10-31 |
Селджен Квонтисел Рисёрч, Инк. |
HYSTON DIMETHYLASE INHIBITORS
|
WO2016064957A1
(en)
*
|
2014-10-22 |
2016-04-28 |
Bristol-Myers Squibb Company |
Bicyclic heteroaryl amine compounds as pi3k inhibitors
|
WO2016064958A1
(en)
*
|
2014-10-22 |
2016-04-28 |
Bristol-Myers Squibb Company |
Heteroaryl substituted pyrrolotriazine amine compounds as pi3k inhibitors
|
MA40933A
(en)
|
2014-11-11 |
2017-09-19 |
Piqur Therapeutics Ag |
DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
|
WO2016106624A1
(en)
*
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
US9586949B2
(en)
|
2015-02-09 |
2017-03-07 |
Incyte Corporation |
Aza-heteroaryl compounds as PI3K-gamma inhibitors
|
US9968604B2
(en)
*
|
2015-04-16 |
2018-05-15 |
Chiesi Farmaceutici S.P.A. |
Chromene derivatives as phoshoinositide 3-kinases inhibitors
|
EP3294737A4
(en)
|
2015-05-12 |
2018-10-03 |
Kalyra Pharmaceuticals, Inc. |
Bicyclic compounds
|
AR106595A1
(en)
|
2015-11-06 |
2018-01-31 |
Incyte Corp |
HETEROCYCLIC COMPOUNDS AS PI3K-g INHIBITORS
|
ES2833955T3
(en)
|
2016-01-05 |
2021-06-16 |
Incyte Corp |
Pyridines substituted with pyrazole / imidazole as PI3K-Gamma inhibitors
|
WO2017223414A1
(en)
|
2016-06-24 |
2017-12-28 |
Incyte Corporation |
HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS
|
WO2018038265A1
(en)
|
2016-08-26 |
2018-03-01 |
田辺三菱製薬株式会社 |
Bicyclic nitrogenated heterocyclic compound
|
WO2018136754A1
(en)
|
2017-01-20 |
2018-07-26 |
Massachusetts Institute Of Technology |
Injectable polymer micro-depots for controlled local drug delivery
|
TWI674261B
(en)
|
2017-02-17 |
2019-10-11 |
美商英能腫瘤免疫股份有限公司 |
Nlrp3 modulators
|
CU24615B1
(en)
|
2017-07-24 |
2022-07-08 |
Novartis Ag |
COMPOUNDS TO TREAT CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
|
US10988454B2
(en)
|
2017-09-14 |
2021-04-27 |
Abbvie Overseas S.À.R.L. |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
|
WO2019079540A1
(en)
|
2017-10-18 |
2019-04-25 |
Epizyme, Inc. |
Amine-substituted heterocyclic compounds as ehmt2 inhibitors, salts thereof, and methods of synthesis thereof
|
EP4006034A1
(en)
|
2017-10-18 |
2022-06-01 |
Incyte Corporation |
Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors
|
CN111511746B
(en)
|
2017-12-19 |
2024-01-09 |
特普医药公司 |
Macrocyclic compounds for the treatment of diseases
|
CN111491925B
(en)
|
2017-12-21 |
2023-12-29 |
巴斯夫欧洲公司 |
Pesticidal compounds
|
KR20200111163A
(en)
|
2017-12-21 |
2020-09-28 |
베링거 인겔하임 인터내셔날 게엠베하 |
Novel benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
|
MA53561A
(en)
*
|
2018-09-05 |
2022-05-11 |
Incyte Corp |
CRYSTALLINE FORMS OF A PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITOR
|